Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Cytosorbents Cor (CTSO)

Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
CytoSorbents: Q4 Earnings Snapshot AP - Wed Mar 25, 3:33PM CDT

CytoSorbents: Q4 Earnings Snapshot

CTSO : 0.6142 (+0.36%)
CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026 PR Newswire - Thu Mar 19, 8:44AM CDT

PRINCETON, N.J. , March 19, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...

CTSO : 0.6142 (+0.36%)
CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights PR Newswire - Thu Mar 5, 6:00AM CST

PRINCETON, N.J. , March 5, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 0.6142 (+0.36%)
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update PR Newswire - Mon Jan 12, 6:00AM CST

Fourth quarter and Full-Year 2025 revenue are expected to be approximately   $9.2 million and $37.0 million, respectively, with expected Q4 gross margins in the range of 73% to 75%

CTSO : 0.6142 (+0.36%)
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025 PR Newswire - Wed Dec 10, 2025

PRINCETON, N.J. , Dec. 10, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 0.6142 (+0.36%)
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London PR Newswire - Mon Nov 17, 2025

PRINCETON, N.J. , Nov. 17, 2025 /PRNewswire/ --  CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 0.6142 (+0.36%)
CytoSorbents: Q3 Earnings Snapshot AP - Thu Nov 13, 2025

CytoSorbents: Q3 Earnings Snapshot

CTSO : 0.6142 (+0.36%)
CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update PR Newswire - Thu Nov 13, 2025

PRINCETON, N.J. , Nov. 13, 2025 /PRNewswire/ --  CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 0.6142 (+0.36%)
CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London PR Newswire - Tue Nov 11, 2025

PRINCETON, N.J. , Nov. 11, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 0.6142 (+0.36%)
CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights PR Newswire - Thu Oct 30, 2025

PRINCETON, N.J. , Oct. 30, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 0.6142 (+0.36%)

Barchart Exclusives

As OpenAI Drags Down Chip Stocks, Is Applied Materials Stock a Buy, Sell, or Hold? Barchart - 3 minutes ago
Applied Materials shares are tanking on reports OpenAI missed revenue and user growth targets. But there are reasons to buy the dip in AMAT stock today. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.